A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA
Clinical trial NCT06049342 · UNKNOWN
Trial details
- NCT number
- NCT06049342
- Sponsor
- Nuwacell Biotechnologies Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-25
- Primary completion
- 2024-06-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.